Praxis Gets FDA Breakthrough Designation for Essential Tremor Drug

Praxis Precision Medicines has won Food and Drug Administration breakthrough-therapy designation for its ulixacaltamide drug candidate for the treatment of patients with essential tremor.
TMCnet

Praxis Precision Medicines Announces the FDA Has Granted Breakthrough Therapy Designation for Ulixacaltamide HCl in Essential Tremor

In December 2025, Praxis announced the successful completion of its pre-NDA meeting with the FDA, including the receipt of written feedback and an in-person meeting. The Company has aligned with the ...

Corrie's Rob Mallard’s life off screen – co-star romance to devastating diagnosis

In the past, Rob was romantically linked with fellow cast member Daniel Brocklebank, who portrays vicar Billy Mayhew on the ...
Healio

Q&A: Noninvasive focused ultrasound solves spatial resolution issues in brain treatment

The question of whether invasive or noninvasive methods provide the best possible outcomes for patients with ...
IEEE

Tremor Suppression Using Functional Electrical Stimulation

Abstract: Parkinson’s disease (PD) and essential tremor are two major causes of pathological tremor among people over 60 years old. Due to the side effects and complications of traditional tremor ...
IEEE

Real-World Parkinson’s Hand Tremor Detection Using Ensemble Learning Techniques

Abstract: Hand tremor is a major motor symptom of Parkinson’s disease (PD) that seriously affects the life quality of patients. Conventional tremor detection methods have mainly focused on resting ...